L. Becker Hewes - 15 Oct 2021 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Chief Medical Officer
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
15 Oct 2021
Net transactions value
-$26,550
Form type
4
Filing time
19 Oct 2021, 16:04:09 UTC
Previous filing
17 Sep 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $48,289 +729 +2.8% $66.24 26,916 15 Oct 2021 Direct F1
transaction BPMC Common Stock Sale $74,839 -729 -2.7% $102.66 26,187 15 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -729 -2.8% $0.000000 25,521 15 Oct 2021 Common Stock 729 $66.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Effected pursuant to a trading plan adopted on August 13, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 This option was granted on June 1, 2020. This option vested with respect to 25% of the shares underlying the option on June 1, 2021 and as to an additional 1/48th of the shares underlying the option each month thereafter.